Phase-III Clinical Studies on Poly Herbal Anti-Diabetic Formulation
A phase 3 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 500 participants.
Also called NCT07279909
- Study
- In this atlas
Overview
- Design
- Interventional study; non-randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 500 participants
- Sponsor
- Hamdard University
- Registry
-
NCT07279909
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (anticipated)
- Countries
- Pakistan
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT07279909. Non-randomized; no masking; primary purpose treatment. Start 2024-03-09 (actual); primary completion 2025-08-01 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Phase-III Clinical Studies on Poly Herbal Anti-Diabetic Formulation
- Condition
- Diabetes Type 2
- Condition
- Diabetes Mellitus, Experimental
- Condition
- HbA1c (A1C)
- Condition
- Urinary Glucose
- Condition
- Ability of Experimental Drug to Lower HbA1c Compare to Metformin
- Intervention (Drug)
- DIAB-PHC1
- Intervention (Drug)
- Metformin
- Lead sponsor
- Hamdard University
- Collaborator
- Jinnah Postgraduate Medical Centre
Record details
- Record id
cardio:ct-nct07279909- Content hash
972256e2a2a99a8565dd0ec9b87aded91ab9a6c873413f9df2ac3164ccc85ae3